Bevacizumab-induced hand-foot syndrome: circumscribed typeMUNEHIRO, A; YONEDA, K; YOKOMISE, H et al.British journal of dermatology (1951). 2010, Vol 162, Num 6, pp 1411-1413, issn 0007-0963, 3 p.Article

Kutane Nebenwirkungen der medikamentösen Tumortherapie : Medikamentöse Tumortherapie in der dermatologie = Cutaneous side effects of medical tumor therapy : Medical tumor therapy in dermatologyDEGEN, A; ALTER, M; SCHENCK, F et al.Der Hautarzt. 2011, Vol 62, Num 6, pp 444-450, issn 0017-8470, 7 p.Article

Kutane Nebenwirkungen der Multikinaseinhibitoren Sorafenib und Sunitinib : Neue kutane Arzneimittelnebenwirkunger = Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib : New cutaneous side effects of drugsWOLLENBERG, A; STAEHLER, M; EAMES, T et al.Der Hautarzt. 2010, Vol 61, Num 8, pp 662-667, issn 0017-8470, 6 p.Article

Hand-Fuß-syndrom bei einem Patienten unter Capecitabin-Therapie = Hand-foot syndrome with capecitabine therapyMARINI, A; HENGGE, U. R.Hautarzt. 2007, Vol 58, Num 6, pp 532-536, issn 0017-8470, 5 p.Article

Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome)LORUSSO, D; DI STEFANO, A; CARONE, V et al.Annals of oncology. 2007, Vol 18, Num 7, pp 1159-1164, issn 0923-7534, 6 p.Article

The hand-foot syndrome - : a frequent secondary manifestation in antineoplastic chemotherapyJANUSCH, M; FISCHER, M; MARSCH, W. Ch et al.EJD. European journal of dermatology. 2006, Vol 16, Num 5, pp 494-499, issn 1167-1122, 6 p.Article

Eritema acral inducido por quimioterapia : estudio clínico e histopatológico de 44 casos = CHEMOTHERAPY-INDUCED ACRAL ERYTHEMA : A CLINICAL AND HISTOPATHOLOGIC STUDY OF 44 CASESHUESO, L; SANMARTIN, O; NAGORE, E et al.Actas dermo-sifiliográficas (Ed. impresa). 2008, Vol 99, Num 4, pp 281-290, issn 0001-7310, 10 p.Article

Pegylated liposomal doxorubicin-associated hand-foot syndrome : Recommendations of an international panel of expertsVON MOOS, Roger; THUERLIMANN, Beat J. K; LADEMANN, Jürgen et al.European journal of cancer (1990). 2008, Vol 44, Num 6, pp 781-790, issn 0959-8049, 10 p.Article

A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapyCHUA, Daniel T. T; SHAM, Jonathan S. T; AU, Gordon K. H et al.Oral oncology (1997). 2003, Vol 39, Num 4, pp 361-366, issn 1368-8375, 6 p.Article

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeMOEHLER, M; MADERER, A; SCHÜTZ, M et al.European journal of cancer (1990). 2014, Vol 50, Num 18, pp 3125-3135, issn 0959-8049, 11 p.Article

Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumorsVALLE, Juan W; FAIVRE, Sandrine; HUBNER, Richard A et al.Cancer treatment reviews. 2014, Vol 40, Num 10, pp 1230-1238, issn 0305-7372, 9 p.Article

Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution surveyKAWAGUCHI, K; ISHIGURO, H; MORITA, S et al.Breast cancer research and treatment. 2011, Vol 130, Num 2, pp 627-634, issn 0167-6806, 8 p.Article

Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and SunitinibLIPWORTH, Adam D; ROBERT, Caroline; ZHU, Andrew X et al.Oncology. 2009, Vol 77, Num 5, pp 257-271, issn 0030-2414, 15 p.Article

Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysisVISWANATH REDDY BELUM; SHENHONG WU; LACOUTURE, Mario E et al.Investigational new drugs. 2013, Vol 31, Num 4, pp 1078-1086, issn 0167-6997, 9 p.Article

The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective studyZHANG, Rong-Xin; WU, Xiao-Jun; LU, Shi-Xun et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 6, pp 953-957, issn 0171-5216, 5 p.Article

The Pathogenetic Mechanism of Anthracycline-induced Palmar-plantar ErythrodysesthesiaMARTSCHICK, A; SEHOULI, J; PATZELT, A et al.Anticancer research. 2009, Vol 29, Num 6, pp 2307-2313, issn 0250-7005, 7 p.Article

Unilaterale akrale Nekrosen als Abortivform einer palmoplantaren Erythrodysasthesie : Patientin mit unilateralen akralen Nekrosen unter Capecitabine -Therapie bei metastasiertem Mammakarzinom = Unilateral acral necrosis as a minor form of hand-foot syndrome. Patient with unilateral acral necrosis secondary to capecitabine therapy for metastatic breast cancerSAUTER, C; SABOROWSKI, A; OCKENFELS, H.-M et al.Hautarzt. 2007, Vol 58, Num 7, pp 619-622, issn 0017-8470, 4 p.Article

Hand-foot syndromeJUCGLA, A; SAIS, G.Journal of clinical oncology. 1997, Vol 15, Num 9, issn 0732-183X, p. 3164Article

Lack of Association Between Excretion of Sorafenib in Sweat and Hand-Foot Skin ReactionJAIN, Lokesh; GARDNER, Erin R; FIGG, William D et al.Pharmacotherapy. 2010, Vol 30, Num 1, pp 52-56, issn 0277-0008, 5 p.Article

Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndromeMANGANA, Joanna; ZIPSER, Marie C; CONRAD, Curdin et al.EJD. European journal of dermatology. 2008, Vol 18, Num 5, pp 566-570, issn 1167-1122, 5 p.Article

A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modificationsCORRIE, P. G; BULUSU, R; HILL, M et al.British journal of cancer. 2012, Vol 107, Num 4, pp 585-587, issn 0007-0920, 3 p.Article

Recurrent salmonella osteomyelitis of both hands in a child with no signs of haemoglobinopathy: Follow-up until 19 years of ageHAGA, Nobuhiko; TAKIKAWA, Kazuharu; NAKAMURA, Shigeru et al.Scandinavian journal of plastic and reconstructive surgery and hand surgery. 2003, Vol 37, Num 5, pp 315-317, issn 0284-4311, 3 p.Article

Palifermin-induced acral erythrodysaesthesia variant in the treatment of acute myeloid leukaemiaMILNE, Olivia; CUTTS, Briony; MCLEAN, Catriona et al.Australasian journal of dermatology. 2011, Vol 52, Num 1, pp 59-61, issn 0004-8380, 3 p.Article

Candidate mechanisms for capecitabine-related hand-foot syndromeMILANO, Gérard; ETIENNE-GRIMALDI, Marie-Christine; MARI, Mireille et al.British journal of clinical pharmacology. 2008, Vol 66, Num 1, pp 88-95, issn 0306-5251, 8 p.Article

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancerMUHAMMAD WASIF SAIF; JIA LI; LAMB, Lynne et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 373-380, issn 0344-5704, 8 p.Article